PerkinElmer Stock To Go Ex-dividend Tomorrow (PKI)

NEW YORK ( TheStreet) -- The ex-dividend date for PerkinElmer (NYSE: PKI) is tomorrow, April 18, 2012. Owners of shares as of market close today will be eligible for a dividend of 7 cents per share. At a price of $26.35 as of 9:30 a.m. ET, the dividend yield is 1.1%.

The average volume for PerkinElmer has been 1.1 million shares per day over the past 30 days. PerkinElmer has a market cap of $3.04 billion and is part of the health care sector and health services industry. Shares are up 30.8% year to date as of the close of trading on Monday.

PerkinElmer, Inc. provides technology, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates in two segments, Human Health and Environmental Health. The company has a P/E ratio of 2626, above the average health services industry P/E ratio of 382.1 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates PerkinElmer as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full PerkinElmer Ratings Report.

See our dividend calendar or top-yielding stocks list.
null

If you liked this article you might like

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Takes Cautious Approach to M&A

PerkinElmer Takes Cautious Approach to M&A

PerkinElmer Medical Imaging Unit Sale Could Be in the Works

PerkinElmer Medical Imaging Unit Sale Could Be in the Works

Trade-Ideas: PerkinElmer (PKI) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas: PerkinElmer (PKI) Is Today's "Barbarian At The Gate" Stock

Jim Cramer's 'Mad Money' Recap: Short-Term Pain? Try Investing for Long-Term Gain

Jim Cramer's 'Mad Money' Recap: Short-Term Pain? Try Investing for Long-Term Gain